CWC Advisors »

Tg Therapeutics shares owned by CWC Advisors

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by CWC Advisors from 13F filings

Historical chart of CWC Advisors investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by CWC Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by CWC Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $378k 16k 23.39

More positions owned by CWC Advisors

Apple (AAPL)
Vanguard Bd Index Fds Vanguard Ultra (VUSB)
Vanguard Scottsdale Fds Short Term Treas (VGSH)
Vanguard Scottsdale Fds Inter Term Treas (VGIT)
Broadcom (AVGO)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Select Sector Spdr Tr Energy (XLE)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Blackstone Secd Lending Common Stock (BXSL)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Select Sector Spdr Tr Sbi Healthcare (XLV)
Affiliated Managers (AMG)
Goldman Sachs (GS)
Select Sector Spdr Tr Sbi Cons Discr (XLY)
Microsoft Corporation (MSFT)

View all positions for CWC Advisors

Top funds holding Tg Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Pictet Asset Management Holding SA
Geode Capital Management
Woodline Partners
Goldman Sachs Group
Soleus Capital Management
Susquehanna International
Opaleye Management
Nuveen Asset Management
Deep Track Capital
Bank of America Corporation
Hood River Capital Management
Northern Trust

View all funds holding Tg Therapeutics